Fig 1.
PE = pre-eclampsia, SGA = small for gestational age, AGA = appropriate for gestational age.
Table 1.
Inclusion and exclusion criteria for high-risk women.
Table 2.
Baseline characteristics of study groups.
Table 3.
Pregnancy characteristics of study groups.
Table 4.
Distribution of pre-eclampsia phenotypes.
Table 5.
Geometric mean plasma hemopexin concentrations (mg/ml) by subgroups at three different sampling points during pregnancy.
A before adjustment for body mass index, B after adjustment for body mass index.
Table 6.
Geometric mean plasma alpha-1-microglobulin concentration (μg/ml) by subgroups at three different sampling points during pregnancy.
Fig 2.
Geometric mean of plasma hemopexin concentration in three study groups by duration of gestation.
The geometric means and the 95% confidence intervals (red bars) of the plasma hemopexin (Hpx) concentration among low-risk women (LRW) and high-risk women who did (HRPE) and did not (HRW) develop pre-eclampsia. Data shown by weeks of gestation (A) before and (B) after adjustment for body mass index.
Fig 3.
Geometric mean of alpha-1-microglobulin concentration in three study groups and in pre-eclamptic women with small for gestational age and appropriate for gestational age fetus by weeks of gestation.
The geometric means of the plasma alpha-1-microglobulin (A1M) concentration by weeks of gestation (A) among low-risk women (LRW) and high-risk women, who developed pre-eclampsia (HRPE) and among high-risk women who did not develop pre-eclampsia (HRW) and (B) among women who developed pre-eclampsia and gave birth to a small for gestational age infant (PESGA) and to an appropriate for gestational age infant (PEAGA). Red bars indicate 95% confidence intervals.